Showing results (271-280 of 9,399) with videos related to
Sort By:
Pageof 940
Clinical Pharmacology and Therapeutics|January 1, 1976
The renal elimination of procainamideR L Galeazzi, L B Sheiner, T Lockwood, et al.Clinical Pharmacology and Therapeutics|April 1, 1975
Effect of tolamolol and propranolol on exercise heart rate and anginaW S Aronow, N Spivacek, W Laverty, et al.Clinical Pharmacology and Therapeutics|January 1, 1976
Evaluation of lorazepam and pentobarbital as surgical premedicantsJ T Conner, N Parson, R L Katz, et al.Clinical Pharmacology and Therapeutics|November 24, 2001
Effect of gemfibrozil on the pharmacokinetics and pharmacodynamics of glimepirideM Niemi, P J Neuvonen, K T KivistöClinical Pharmacology and Therapeutics|November 24, 2001
Early postoperative erythromycin breath test correlates with hepatic cytochrome P4503A activity in liver transplant recipientsL E Schmidt, A K Olsen, K Stentoft, et al.Clinical Pharmacology and Therapeutics|November 24, 2001
Low sodium and furosemide-induced stimulation of the renin system in man is mediated by cyclooxygenase 2M C Kammerl, R M Nüsing, F Schweda, et al.Clinical Pharmacology and Therapeutics|November 24, 2001
Effect of high-dose lansoprazole on intragastic pH in subjects who are homozygous extensive metabolizers of cytochrome P4502C19T Furuta, N Shirai, F Xiao, et al.Clinical Pharmacology and Therapeutics|March 1, 1975
1.3 Bis-(2 chloroethyl)-1-nitrosourea and streptozotocin chemotherapyJ J Lokich, P L Chawla, E FreiClinical Pharmacology and Therapeutics|November 12, 2002
The effects of the human MDR1 genotype on the expression of duodenal P-glycoprotein and disposition of the probe drug talinololWerner Siegmund, Karen Ludwig, Thomas Giessmann, et al.Clinical Pharmacology and Therapeutics|November 12, 2002
Pharmacokinetics and pharmacodynamics of darbepoetin alfa and epoetin in patients undergoing dialysisMichael Allon, Kenneth Kleinman, Michael Walczyk, et al.Pageof 940